Figure 5.
QoL as assessed by EORTC questionnaire at 6 months for different functional scales and global QoL for patients on low- or high-dose IFN-alfa. The mean result at baseline prior to starting IFN-alfa is also given for comparison.
QoL as assessed by EORTC questionnaire at 6 months for different functional scales and global QoL for patients on low- or high-dose IFN-alfa. The mean result at baseline prior to starting IFN-alfa is also given for comparison.
